Audit in process? Call the number on your audit letter to get options.
Site Logo
Health care professionals website
DPL Global Search
DPL Utility Nav
DPL Main Nav
DPL Global Search
DPL Utility Nav
Breadcrumbs
SubHero Banner
RxNews®
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Enbrel® (etanercept) – New indication
October 18, 2023 - The FDA approved Amgen’s Enbrel (etanercept), for the treatment of active juvenile psoriatic arthritis (JPsA) in pediatric patients 2 years of age and older.
